Highly expressed genes in ATL cells compared with normal CD4+ and CD4+CD45RO+ T cells
. | . | . | Fold change . | . | |
---|---|---|---|---|---|
Accession no. . | Symbol . | Gene . | CD4+ . | CD45RO+ . | |
AF070648 | CAV1 | Caveolin 1* | 34.82 | 49.74 | |
AF150241 | PGDS | Prostaglandin D2 synthase | 31.21 | 12.56 | |
AL080181 | TSLC1 | Tumor suppressor in lung cancer 1 | 30.36 | 36.86 | |
M36711 | TFAP2A | Transcription factor AP-2 alpha | 19.14 | 11.28 | |
AF079529 | PDE8B | Phosphodiesterase 8B | 17.58 | 13.07 | |
AB002305 | ARNT2 | Aryl-hydrocarbon receptor nuclear translocator 2 | 17.15 | 22.59 | |
X58288 | PTPRM | Protein tyrosine phosphatase, receptor type, M | 15.89 | 5.12 | |
Y00664 | NMYC | V-myc myelocytomatosis viral related oncogene, neuroblastoma | 15.30 | 12.11 | |
J03802 | PTHLH | Parathyroid hormone-like hormone*† | 14.10 | 8.68 | |
AF022797 | KCNN4 (hKCa4) | Potassium intermediate/small conductance calcium-activated | 12.78 | 6.05 | |
X00948 | RLN2 | Relaxin 2 (H2) | 12.02 | 8.85 | |
M25753 | CCNB1 | CyclinB1 | 11.53 | 5.33 | |
W26466 | NA | 32f11 | 11.20 | 10.83 | |
X65233 | ZNF80 | Zinc finger protein 80 (pT17) | 10.54 | 7.10 | |
U49089 | DLG3 | Discs, large (Drosophila) homolog 3 | 9.60 | 6.79 | |
AL080146 | CCNB2 | CyclinB2 | 9.56 | 7.18 | |
AI760162 | NA | wg58e09.x1 | 9.19 | 4.34 | |
D87119 | TRB2 | Tribbles homolog 2 | 9.18 | 4.24 | |
AF030107 | RGS13 | Regulator of G-protein signaling 13 | 8.33 | 9.41 | |
AF024714 | AIM2 | Interferon-inducible protein (AIM2) absent in melanoma | 8.26 | 5.74 | |
D13633 | DLG7 | Discs large homolog 7 | 7.53 | 3.06 | |
M37712 | CDC2L2 | Cell division cycle 2-like 2 | 7.16 | 7.26 | |
X01057 | IL2RA | Interleukin 2 receptor, alpha*† | 6.78 | 3.73 | |
AI375913 | NA | tc14c08.x1 | 6.62 | 4.23 | |
AB020316 | UST | Uronyl-2-sulfotransferase | 6.58 | 3.72 | |
L25876 | CDKN3 | CIP2 (cyclin-dependent interacting protein 2) cyclin-dependent kinase inhibitor 3 | 6.39 | 8.06 | |
D38073 | MCM3 | Minichromosome maintenance deficient 3 | 6.34 | 2.71 | |
AB014566 | DAAM1 | Disheveled associated activator of morphogenesis 1 | 6.27 | 5.55 | |
AF007155 | LOC254531 | PISC domain containing hypothetical protein | 6.14 | 4.20 | |
L47276 | HUMTOPATR | Homo sapiens alpha topoisomerase truncated-form mRNA | 6.12 | 4.03 | |
U37426 | KIF11 | Kinesin family member 11 | 6.12 | 3.15 | |
AB012911 | FZD6 | Frizzled homolog 6 | 6.12 | 5.48 | |
AL080121 | DKFZp564O0823 | Highly similar to rat castration induced prostatic apoptosis related protein-1 | 6.10 | 6.96 | |
X83490 | TNFRSF6 | Tumor necrosis factor receptor superfamily member 6* (Fas/APO-1) | 6.02 | 3.85 | |
AL050107 | TAZ | Transcriptional co-activator with PDZ (PSD-95, DLG, and ZO-1)—binding motif | 5.81 | 5.67 | |
J04088 | TOP2A | Topoisomerase (DNA) II alpha | 5.59 | 4.52 | |
D42055 | NEDD4 | Neural precursor cell expressed, developmentally down-regulated 4 | 5.47 | 2.02 | |
D38251 | POLR2E | Polymerase (RNA) II (DNA directed) polypeptide E | 5.40 | 8.51 | |
M74089 | LOC91137 | Hypothetical protein BC017169 | 5.28 | 3.81 | |
D13643 | DHCR24 | 24-dehydrocholesterol reductase | 5.17 | 5.52 | |
D14657 | KIAA0101 | KIAA0101 gene product | 4.94 | 3.93 | |
AA203476 | NA | zx55e01.rl | 4.92 | 2.31 | |
M13755 | GIP2 | Interferon, alpha-inducible protein | 4.86 | 6.20 | |
U63743 | KIF2C | Kinesin family member 2C | 4.69 | 3.78 | |
J03473 | ADPRT | ADP-ribosyltransferase | 4.52 | 3.58 | |
U43916 | EMP1 | Epithelial membrane protein 1 | 4.49 | 2.75 | |
Z70519 | TNFRSF6 | FAS soluble protein* | 4.44 | 2.69 | |
U73379 | UBE2C | Ubiquitin-conjugating enzyme E2C | 4.43 | 4.57 | |
D86062 | C21orf33 | Chromosome 21 open reading frame 33 | 4.41 | 7.29 | |
AI127424 | NA | qb75b02.x1 | 4.36 | 6.10 | |
AC004528 | C19orf6 | Chromosome 19 open reading frame 6 | 4.31 | 4.16 | |
AL050069 | DOK5 | Docking protein 5 | 4.27 | 5.45 | |
U81561 | PTPRN2 | Protein tyrosine phosphatase, receptor type, N polypeptide 2 | 4.24 | 5.04 | |
M15205 | TK1 | Thymidine kinase 1, soluble | 4.21 | 4.71 | |
M84443 | GALK2 | Galactokinase 2 | 4.09 | 2.29 | |
D63861 | PPID | Peptidylprolyl isomerase D (cyclophilin D) | 4.08 | 2.34 | |
X02883 | HSTCRAC | Human gene for T-cell receptor alpha chain C region | 4.05 | 2.81 | |
D00596 | TYMS | Thymidylate synthetase | 4.03 | 4.17 | |
U03494 | TFCP2 | Transcription factor CP2 (CCAAT protein) | 3.99 | 3.15 | |
U31601 | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 3.95 | 3.48 | |
AF009426 | C18orf1 | Chromosome 18 open reading frame 1 | 3.93 | 2.87 | |
AL022398 | ADORA2BP | Adenosine A2b receptor pseudogene | 3.90 | 2.80 | |
M97935 | STAT1 | Signal transducer and activator of transcription 1 | 3.89 | 4.36 | |
AA919102 | NA | o184h02.sl | 3.86 | 2.11 | |
U88964 | ISG20 | Interferon-stimulated gene | 3.81 | 3.21 | |
AJ010953 | ATP2CI | ATPase, Ca++ transporting, type 2C, member 1 | 3.73 | 2.87 | |
U53003 | C21orf33 | Chromosome 21 open reading frame 33 | 3.69 | 2.76 | |
M36711 | NA | DNA-binding protein Ap-2 | 3.67 | 3.09 | |
M34641 | FGFR1 | Fibroblast growth factor receptor 1 | 3.62 | 2.37 | |
AI652660 | wb30c10.x1 | 3.62 | 3.47 | ||
AJ000534 | SGCE | Sarcoglycan, epsilon | 3.61 | 3.07 | |
D50920 | THRAP4 | Thyroid hormone receptor associated protein 4 | 3.48 | 2.05 | |
AB024704 | TPX2 | Microtubule-associated protein homolog | 3.45 | 3.20 | |
X14798 | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 | 3.44 | 3.36 | |
Y11681 | Y11681 | Mitochondrial ribosomal protein S12 | 3.44 | 7.90 | |
D26155 | SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 3.42 | 3.10 | |
AL031737 | NA | Human DNA sequence from clone 8B22 on chromosome 1p35.1-36.21 | 3.42 | 2.35 | |
M86699 | TTK | TTK (threonine/tyrosine kinase) protein kinase | 3.40 | 2.38 | |
U16799 | ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | 3.39 | 3.81 | |
AB018270 | MYO1D | Myosin ID | 3.34 | 2.57 | |
U76638 | BARD1 | BRCA1 (breast cancer 1) associated RING domain 1 | 3.34 | 2.62 | |
AB013452 | ATP8A1 | ATPase, aminophospholipid transporter (APLT), class 1, type 8A, member 1 | 3.32 | 3.29 | |
Y11525 | CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 3.32 | 3.34 | |
M34423 | GLB1 | Galactosidase, beta 1 | 3.31 | 4.04 | |
AA203213 | NA | zx57e04.r1 | 3.31 | 3.49 | |
X64624 | POU4F1 | POU (Pit, Oct, Unc) domain, class 4, transcription factor 1 | 3.31 | 3.92 | |
AB018271 | BPAG1 | Bullous pemphigoid antigen 1 | 3.25 | 2.12 | |
LI3435 | NA | Human chromosome 3p21.1 gene sequence | 3.24 | 2.92 | |
AF055993 | SAP30 | Sin3-associated polypeptide | 3.18 | 3.47 | |
U29332 | FHL2 | Four and a half LIM (Lin-1, Tsl-1, MEC-3) domains 2 | 3.16 | 3.60 | |
AI540958 | NA | Homo sapiens cDNA, 5 end/clone_end=5 | 3.15 | 3.59 | |
D38522 | SYT11 | Synaptotagmin XI | 3.09 | 3.58 | |
U01038 | PLK1 | Polo-like kinase 1 | 3.07 | 3.40 | |
X74262 | RBBP4 | Retinoblastoma binding protein 4 | 3.05 | 5.58 | |
L23959 | TFDP1 | Transcription factor Dp-1 (E2F dimerization partner-1) | 3.03 | 3.76 | |
M87434 | OAS2 | 2′-5′-oligoadenylate synthetase 2 | 3.02 | 2.96 | |
M25280 | SELL | Selectin L (lymphocyte adhesion molecule 1) | 3.02 | 3.31 | |
M63488 | RPA1 | Replication protein A1 | 3.01 | 3.39 | |
U78190 | GCHFR | GTP cyclohydrolase I feedback regulatory protein | 3.01 | 2.09 | |
AF067656 | ZWINT | ZW10 interactor | 2.97 | 2.50 | |
M15024 | MYB | v-myb myeloblastosis viral oncogene homolog | 2.97 | 4.54 | |
M81830 | SSTR2 | Somatostatin receptor 2 | 2.96 | 3.33 | |
D28364 | ANXA11 | Annexin II, 5 | 2.96 | 6.05 | |
M63838 | FI16 | Interferon, gamma-inducible protein 16 | 2.92 | 3.05 | |
X72889 | NA | NA | 2.91 | 2.45 | |
AC003108 | Anxa6 | Annexin VI | 2.84 | 3.79 | |
L07541 | RFC3 | Replication factor C (activator 1) 3 | 2.83 | 2.67 | |
D78261 | IRF4 | Interferon regulatory factor 4* | 2.83 | 3.14 | |
AA005018 | NA | zh96a09.rl | 2.83 | 2.12 | |
AA310786 | NA | EST181572 Homo sapiens cDNA | 2.78 | 2.29 | |
M87284 | OAS2 | 2′-5′-oligoadenylate synthetase 2 | 2.77 | 3.11 | |
U09813 | ATP5G3 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9) isoform 3 | 2.76 | 4.85 | |
AC005253 | UBA52 | Ubiquitin A-52 residue ribosomal protein fusion product 1 | 2.75 | 2.85 | |
AF070523 | JWA | Cytoskeleton related vitamin A responsive protein | 2.75 | 2.29 | |
U38545 | PLD1 | Phospholipase D1, phophatidylcholine-specific | 2.74 | 2.17 | |
U25182 | PRDX4 | Peroxiredoxin 4 | 2.73 | 3.10 | |
AF022385 | PDCD10 | Programmed cell death 10 | 2.73 | 2.09 | |
AF000416 | EXTL2 | Exostoses (multiple)-like 2 | 2.73 | 2.13 | |
D26361 | KIF14 | Kinesin family member 14 | 2.72 | 2.47 | |
AF064084 | ICMT | Isoprenylcysteine carboxyl methyltransferase | 2.70 | 4.31 | |
X98248 | SORT1 | Sortilin 1 | 2.69 | 5.01 | |
U65410 | MAD2L1 | MAD2 (mitotic arrest-deficient 2) mitotic arrest deficient-like 1 | 2.66 | 2.73 | |
U51004 | HINT1 | Histidine triad nucleotide binding protein 1 | 2.64 | 2.09 | |
M23379 | RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 2.64 | 2.43 | |
X57398 | PM5 | pM5 protein | 2.63 | 2.65 | |
X65550 | MK167 | Antigen identified by monoclonal antibody Ki-67 | 2.60 | 3.41 | |
J05614 | PCNA | Proliferating cell nuclear antigen† | 2.59 | 2.50 | |
X67951 | PRDX1 | Peroxiredoxin 1 | 2.58 | 2.16 | |
M11507 | TFRC | Transferrin receptor (p90, CD71) | 2.57 | 2.59 | |
D26599 | PSMB2 | Proteasome (prosome, macropain) subunit, beta type, 2 | 2.55 | 2.91 | |
AF053551 | MTX2 | Metaxin 2 | 2.53 | 3.54 | |
AF016898 | BATF | Basic leucine zipper transcription factor, AT-like | 2.50 | 2.04 | |
AF055993 | SAP30 | sin3-associated polypeptide | 2.49 | 2.73 | |
D14710 | ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 | 2.48 | 2.01 | |
U09564 | NA | Human serine kinase | 2.48 | 2.51 | |
AL109672 | P24B | Integral type I protein | 2.48 | 3.85 | |
AI056696 | NA | oz26h05.x1 | 2.44 | 2.65 | |
M13228 | MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived | 2.44 | 2.78 | |
AI566877 | NA | tn24f02.x1 | 2.44 | 2.25 | |
L09235 | ATP6V1A | ATPase, H+ transporting, lysosomal | 2.42 | 5.18 | |
X51688 | CCNA2 | Cyclin A2 | 2.36 | 2.45 | |
U13695 | PMS1 | Postmeiotic segregation increased 1 | 2.34 | 2.17 | |
AB007455 | TP53AP1 | TP53 activated protein 1 | 2.33 | 2.77 | |
D44497 | CORO1A | Coronin, actin binding protein, 1A | 2.33 | 2.77 | |
AA255502 | NA | zr85b06.r1 | 2.33 | 2.78 | |
X73066 | NME1 | Non-metastatic cells 1, protein (NM23A) expressed in | 2.32 | 3.00 | |
AI347088 | NA | qp60d09.x1 | 2.32 | 2.21 | |
U37689 | POLR2H | Polymerase (RNA) II (DNA directed) polypeptide H | 2.32 | 2.13 | |
U86529 | GSTZ1 | Glutathione transferase zeta 1 | 2.32 | 2.28 | |
J03133 | SP1 | SP1 (SV40 promoter 1) transcription factor | 2.31 | 4.73 | |
AB007447 | FLN29 | FLN29 gene product (TNF receptor factor-like protein) | 2.30 | 2.34 | |
X74008 | PPP1CC | Protein phosphatase 1, catalytic subunit, gamma isoform | 2.30 | 2.07 | |
U56833 | VBP1 | von Hippel-Lindau binding protein 1 | 2.29 | 2.16 | |
AF020038 | IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | 2.29 | 3.40 | |
U63809 | PAWR | PRKC (protein kinase C), apoptosis, WT1, regulator | 2.29 | 2.35 | |
AL050034 | ADPRTL3 | ADP-ribosyltransferase-like 3 | 2.25 | 2.09 | |
M87339 | HUMACT1A | Human replication factor C, 37-kDa subunit | 2.25 | 2.98 | |
AA056747 | NA | zk81f02.s1 | 2.24 | 2.95 | |
U10886 | PTPRJ | Protein tyrosine phosphatase, receptor type, J | 2.23 | 2.52 | |
X84194 | ACYP1 | A-cylphosphatase 1, erythrocyte (common) type | 2.23 | 4.40 | |
AB024401 | ING1 | Inhibitor of growth family, member 1 | 2.20 | 14.85 | |
M19481 | FST | Follistatin | 2.20 | 2.54 | |
AF006084 | ARPC1B | Actin related protein 2/3 complex, subunit 1B, | 2.19 | 3.71 | |
Y00097 | ANXA6 | Annexin A6 | 2.19 | 2.00 | |
D00017 | ANXA2 | Annexin A2 | 2.18 | 2.81 | |
U50079 | HDAC1 | Histone deacetylase 1 | 2.17 | 2.62 | |
AA811338 | NA | ob81g05.sl | 2.17 | 5.19 | |
M97676 | MSX1 | msh homeo box homolog 1 | 2.16 | 3.15 | |
M63573 | PPIB | Peptidylprolyl isomerase B (cyclophilin B) | 2.16 | 2.85 | |
J00314 | OK/SW-cl.56 | beta 5-tubulin | 2.16 | 2.19 | |
U30872 | CENPF | Centromere protein F | 2.16 | 2.43 | |
AA969267 | NA | on57d12.sl | 2.13 | 2.49 | |
AF053306 | BUB1B | Budding uninhibited by benzimidazoles 1 homolog beta | 2.13 | 2.04 | |
AF042384 | BC-2 | Putative breast adenocarcinoma marker | 2.12 | 2.52 | |
U32849 | NMI | N-myc (and STAT) interactor | 2.12 | 2.90 | |
AB028975 | KIAA1052 | KIAA1052 protein | 2.12 | 2.53 | |
AJ000480 | C8FW | Phosphoprotein regulated by mitogenic pathways | 2.11 | 4.49 | |
D50692 | MYCBP | c-myc binding protein | 2.10 | 3.00 | |
M16279 | CD99 | CD99 antigen | 2.10 | 2.94 | |
X69398 | CD47 | CD47 antigen (Rh-related antigen) | 2.09 | 2.17 | |
AF054825 | VAMP5 | Vesicle-associated membrane protein 5 | 2.09 | 2.69 | |
D37984 | RECQL | RecQ protein-like (DNA helicase Q1-like) | 2.09 | 2.27 | |
U90549 | HMGN4 | High mobility group nucleosomal binding domain 4 | 2.09 | 2.16 | |
AF087036 | MSC | Musculin (activated B-cell factor-1) | 2.08 | 2.67 | |
J04058 | ETFA | Electron-transfer-flavoprotein, alpha polypeptide | 2.06 | 2.54 | |
X62534 | HMGB2 | High-mobility group box 2 | 2.04 | 2.26 | |
S57501 | NA | Protein phosphatase 1, alpha catalytic subunit | 2.04 | 2.71 | |
AJ001612 | PSPHL | Phosphoserine phosphatase-like | 2.03 | 2.89 | |
AJ245416 | LSM2 | LSM2 (Sm-like protein 2) homolog, U6 small nuclear RNA associated | 2.03 | 2.18 | |
U91932 | AP3S1 | Adaptor-related protein complex 3, sigma 1 subunit | 2.03 | 2.89 | |
U74612 | FOXM1 | Forkhead box M1 | 2.02 | 2.17 | |
L42243 | IFNAR2 | Interferon (alpha, beta, and omega) receptor 2 | 2.02 | 2.88 |
. | . | . | Fold change . | . | |
---|---|---|---|---|---|
Accession no. . | Symbol . | Gene . | CD4+ . | CD45RO+ . | |
AF070648 | CAV1 | Caveolin 1* | 34.82 | 49.74 | |
AF150241 | PGDS | Prostaglandin D2 synthase | 31.21 | 12.56 | |
AL080181 | TSLC1 | Tumor suppressor in lung cancer 1 | 30.36 | 36.86 | |
M36711 | TFAP2A | Transcription factor AP-2 alpha | 19.14 | 11.28 | |
AF079529 | PDE8B | Phosphodiesterase 8B | 17.58 | 13.07 | |
AB002305 | ARNT2 | Aryl-hydrocarbon receptor nuclear translocator 2 | 17.15 | 22.59 | |
X58288 | PTPRM | Protein tyrosine phosphatase, receptor type, M | 15.89 | 5.12 | |
Y00664 | NMYC | V-myc myelocytomatosis viral related oncogene, neuroblastoma | 15.30 | 12.11 | |
J03802 | PTHLH | Parathyroid hormone-like hormone*† | 14.10 | 8.68 | |
AF022797 | KCNN4 (hKCa4) | Potassium intermediate/small conductance calcium-activated | 12.78 | 6.05 | |
X00948 | RLN2 | Relaxin 2 (H2) | 12.02 | 8.85 | |
M25753 | CCNB1 | CyclinB1 | 11.53 | 5.33 | |
W26466 | NA | 32f11 | 11.20 | 10.83 | |
X65233 | ZNF80 | Zinc finger protein 80 (pT17) | 10.54 | 7.10 | |
U49089 | DLG3 | Discs, large (Drosophila) homolog 3 | 9.60 | 6.79 | |
AL080146 | CCNB2 | CyclinB2 | 9.56 | 7.18 | |
AI760162 | NA | wg58e09.x1 | 9.19 | 4.34 | |
D87119 | TRB2 | Tribbles homolog 2 | 9.18 | 4.24 | |
AF030107 | RGS13 | Regulator of G-protein signaling 13 | 8.33 | 9.41 | |
AF024714 | AIM2 | Interferon-inducible protein (AIM2) absent in melanoma | 8.26 | 5.74 | |
D13633 | DLG7 | Discs large homolog 7 | 7.53 | 3.06 | |
M37712 | CDC2L2 | Cell division cycle 2-like 2 | 7.16 | 7.26 | |
X01057 | IL2RA | Interleukin 2 receptor, alpha*† | 6.78 | 3.73 | |
AI375913 | NA | tc14c08.x1 | 6.62 | 4.23 | |
AB020316 | UST | Uronyl-2-sulfotransferase | 6.58 | 3.72 | |
L25876 | CDKN3 | CIP2 (cyclin-dependent interacting protein 2) cyclin-dependent kinase inhibitor 3 | 6.39 | 8.06 | |
D38073 | MCM3 | Minichromosome maintenance deficient 3 | 6.34 | 2.71 | |
AB014566 | DAAM1 | Disheveled associated activator of morphogenesis 1 | 6.27 | 5.55 | |
AF007155 | LOC254531 | PISC domain containing hypothetical protein | 6.14 | 4.20 | |
L47276 | HUMTOPATR | Homo sapiens alpha topoisomerase truncated-form mRNA | 6.12 | 4.03 | |
U37426 | KIF11 | Kinesin family member 11 | 6.12 | 3.15 | |
AB012911 | FZD6 | Frizzled homolog 6 | 6.12 | 5.48 | |
AL080121 | DKFZp564O0823 | Highly similar to rat castration induced prostatic apoptosis related protein-1 | 6.10 | 6.96 | |
X83490 | TNFRSF6 | Tumor necrosis factor receptor superfamily member 6* (Fas/APO-1) | 6.02 | 3.85 | |
AL050107 | TAZ | Transcriptional co-activator with PDZ (PSD-95, DLG, and ZO-1)—binding motif | 5.81 | 5.67 | |
J04088 | TOP2A | Topoisomerase (DNA) II alpha | 5.59 | 4.52 | |
D42055 | NEDD4 | Neural precursor cell expressed, developmentally down-regulated 4 | 5.47 | 2.02 | |
D38251 | POLR2E | Polymerase (RNA) II (DNA directed) polypeptide E | 5.40 | 8.51 | |
M74089 | LOC91137 | Hypothetical protein BC017169 | 5.28 | 3.81 | |
D13643 | DHCR24 | 24-dehydrocholesterol reductase | 5.17 | 5.52 | |
D14657 | KIAA0101 | KIAA0101 gene product | 4.94 | 3.93 | |
AA203476 | NA | zx55e01.rl | 4.92 | 2.31 | |
M13755 | GIP2 | Interferon, alpha-inducible protein | 4.86 | 6.20 | |
U63743 | KIF2C | Kinesin family member 2C | 4.69 | 3.78 | |
J03473 | ADPRT | ADP-ribosyltransferase | 4.52 | 3.58 | |
U43916 | EMP1 | Epithelial membrane protein 1 | 4.49 | 2.75 | |
Z70519 | TNFRSF6 | FAS soluble protein* | 4.44 | 2.69 | |
U73379 | UBE2C | Ubiquitin-conjugating enzyme E2C | 4.43 | 4.57 | |
D86062 | C21orf33 | Chromosome 21 open reading frame 33 | 4.41 | 7.29 | |
AI127424 | NA | qb75b02.x1 | 4.36 | 6.10 | |
AC004528 | C19orf6 | Chromosome 19 open reading frame 6 | 4.31 | 4.16 | |
AL050069 | DOK5 | Docking protein 5 | 4.27 | 5.45 | |
U81561 | PTPRN2 | Protein tyrosine phosphatase, receptor type, N polypeptide 2 | 4.24 | 5.04 | |
M15205 | TK1 | Thymidine kinase 1, soluble | 4.21 | 4.71 | |
M84443 | GALK2 | Galactokinase 2 | 4.09 | 2.29 | |
D63861 | PPID | Peptidylprolyl isomerase D (cyclophilin D) | 4.08 | 2.34 | |
X02883 | HSTCRAC | Human gene for T-cell receptor alpha chain C region | 4.05 | 2.81 | |
D00596 | TYMS | Thymidylate synthetase | 4.03 | 4.17 | |
U03494 | TFCP2 | Transcription factor CP2 (CCAAT protein) | 3.99 | 3.15 | |
U31601 | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 3.95 | 3.48 | |
AF009426 | C18orf1 | Chromosome 18 open reading frame 1 | 3.93 | 2.87 | |
AL022398 | ADORA2BP | Adenosine A2b receptor pseudogene | 3.90 | 2.80 | |
M97935 | STAT1 | Signal transducer and activator of transcription 1 | 3.89 | 4.36 | |
AA919102 | NA | o184h02.sl | 3.86 | 2.11 | |
U88964 | ISG20 | Interferon-stimulated gene | 3.81 | 3.21 | |
AJ010953 | ATP2CI | ATPase, Ca++ transporting, type 2C, member 1 | 3.73 | 2.87 | |
U53003 | C21orf33 | Chromosome 21 open reading frame 33 | 3.69 | 2.76 | |
M36711 | NA | DNA-binding protein Ap-2 | 3.67 | 3.09 | |
M34641 | FGFR1 | Fibroblast growth factor receptor 1 | 3.62 | 2.37 | |
AI652660 | wb30c10.x1 | 3.62 | 3.47 | ||
AJ000534 | SGCE | Sarcoglycan, epsilon | 3.61 | 3.07 | |
D50920 | THRAP4 | Thyroid hormone receptor associated protein 4 | 3.48 | 2.05 | |
AB024704 | TPX2 | Microtubule-associated protein homolog | 3.45 | 3.20 | |
X14798 | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 | 3.44 | 3.36 | |
Y11681 | Y11681 | Mitochondrial ribosomal protein S12 | 3.44 | 7.90 | |
D26155 | SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 3.42 | 3.10 | |
AL031737 | NA | Human DNA sequence from clone 8B22 on chromosome 1p35.1-36.21 | 3.42 | 2.35 | |
M86699 | TTK | TTK (threonine/tyrosine kinase) protein kinase | 3.40 | 2.38 | |
U16799 | ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | 3.39 | 3.81 | |
AB018270 | MYO1D | Myosin ID | 3.34 | 2.57 | |
U76638 | BARD1 | BRCA1 (breast cancer 1) associated RING domain 1 | 3.34 | 2.62 | |
AB013452 | ATP8A1 | ATPase, aminophospholipid transporter (APLT), class 1, type 8A, member 1 | 3.32 | 3.29 | |
Y11525 | CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 3.32 | 3.34 | |
M34423 | GLB1 | Galactosidase, beta 1 | 3.31 | 4.04 | |
AA203213 | NA | zx57e04.r1 | 3.31 | 3.49 | |
X64624 | POU4F1 | POU (Pit, Oct, Unc) domain, class 4, transcription factor 1 | 3.31 | 3.92 | |
AB018271 | BPAG1 | Bullous pemphigoid antigen 1 | 3.25 | 2.12 | |
LI3435 | NA | Human chromosome 3p21.1 gene sequence | 3.24 | 2.92 | |
AF055993 | SAP30 | Sin3-associated polypeptide | 3.18 | 3.47 | |
U29332 | FHL2 | Four and a half LIM (Lin-1, Tsl-1, MEC-3) domains 2 | 3.16 | 3.60 | |
AI540958 | NA | Homo sapiens cDNA, 5 end/clone_end=5 | 3.15 | 3.59 | |
D38522 | SYT11 | Synaptotagmin XI | 3.09 | 3.58 | |
U01038 | PLK1 | Polo-like kinase 1 | 3.07 | 3.40 | |
X74262 | RBBP4 | Retinoblastoma binding protein 4 | 3.05 | 5.58 | |
L23959 | TFDP1 | Transcription factor Dp-1 (E2F dimerization partner-1) | 3.03 | 3.76 | |
M87434 | OAS2 | 2′-5′-oligoadenylate synthetase 2 | 3.02 | 2.96 | |
M25280 | SELL | Selectin L (lymphocyte adhesion molecule 1) | 3.02 | 3.31 | |
M63488 | RPA1 | Replication protein A1 | 3.01 | 3.39 | |
U78190 | GCHFR | GTP cyclohydrolase I feedback regulatory protein | 3.01 | 2.09 | |
AF067656 | ZWINT | ZW10 interactor | 2.97 | 2.50 | |
M15024 | MYB | v-myb myeloblastosis viral oncogene homolog | 2.97 | 4.54 | |
M81830 | SSTR2 | Somatostatin receptor 2 | 2.96 | 3.33 | |
D28364 | ANXA11 | Annexin II, 5 | 2.96 | 6.05 | |
M63838 | FI16 | Interferon, gamma-inducible protein 16 | 2.92 | 3.05 | |
X72889 | NA | NA | 2.91 | 2.45 | |
AC003108 | Anxa6 | Annexin VI | 2.84 | 3.79 | |
L07541 | RFC3 | Replication factor C (activator 1) 3 | 2.83 | 2.67 | |
D78261 | IRF4 | Interferon regulatory factor 4* | 2.83 | 3.14 | |
AA005018 | NA | zh96a09.rl | 2.83 | 2.12 | |
AA310786 | NA | EST181572 Homo sapiens cDNA | 2.78 | 2.29 | |
M87284 | OAS2 | 2′-5′-oligoadenylate synthetase 2 | 2.77 | 3.11 | |
U09813 | ATP5G3 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9) isoform 3 | 2.76 | 4.85 | |
AC005253 | UBA52 | Ubiquitin A-52 residue ribosomal protein fusion product 1 | 2.75 | 2.85 | |
AF070523 | JWA | Cytoskeleton related vitamin A responsive protein | 2.75 | 2.29 | |
U38545 | PLD1 | Phospholipase D1, phophatidylcholine-specific | 2.74 | 2.17 | |
U25182 | PRDX4 | Peroxiredoxin 4 | 2.73 | 3.10 | |
AF022385 | PDCD10 | Programmed cell death 10 | 2.73 | 2.09 | |
AF000416 | EXTL2 | Exostoses (multiple)-like 2 | 2.73 | 2.13 | |
D26361 | KIF14 | Kinesin family member 14 | 2.72 | 2.47 | |
AF064084 | ICMT | Isoprenylcysteine carboxyl methyltransferase | 2.70 | 4.31 | |
X98248 | SORT1 | Sortilin 1 | 2.69 | 5.01 | |
U65410 | MAD2L1 | MAD2 (mitotic arrest-deficient 2) mitotic arrest deficient-like 1 | 2.66 | 2.73 | |
U51004 | HINT1 | Histidine triad nucleotide binding protein 1 | 2.64 | 2.09 | |
M23379 | RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 2.64 | 2.43 | |
X57398 | PM5 | pM5 protein | 2.63 | 2.65 | |
X65550 | MK167 | Antigen identified by monoclonal antibody Ki-67 | 2.60 | 3.41 | |
J05614 | PCNA | Proliferating cell nuclear antigen† | 2.59 | 2.50 | |
X67951 | PRDX1 | Peroxiredoxin 1 | 2.58 | 2.16 | |
M11507 | TFRC | Transferrin receptor (p90, CD71) | 2.57 | 2.59 | |
D26599 | PSMB2 | Proteasome (prosome, macropain) subunit, beta type, 2 | 2.55 | 2.91 | |
AF053551 | MTX2 | Metaxin 2 | 2.53 | 3.54 | |
AF016898 | BATF | Basic leucine zipper transcription factor, AT-like | 2.50 | 2.04 | |
AF055993 | SAP30 | sin3-associated polypeptide | 2.49 | 2.73 | |
D14710 | ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 | 2.48 | 2.01 | |
U09564 | NA | Human serine kinase | 2.48 | 2.51 | |
AL109672 | P24B | Integral type I protein | 2.48 | 3.85 | |
AI056696 | NA | oz26h05.x1 | 2.44 | 2.65 | |
M13228 | MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived | 2.44 | 2.78 | |
AI566877 | NA | tn24f02.x1 | 2.44 | 2.25 | |
L09235 | ATP6V1A | ATPase, H+ transporting, lysosomal | 2.42 | 5.18 | |
X51688 | CCNA2 | Cyclin A2 | 2.36 | 2.45 | |
U13695 | PMS1 | Postmeiotic segregation increased 1 | 2.34 | 2.17 | |
AB007455 | TP53AP1 | TP53 activated protein 1 | 2.33 | 2.77 | |
D44497 | CORO1A | Coronin, actin binding protein, 1A | 2.33 | 2.77 | |
AA255502 | NA | zr85b06.r1 | 2.33 | 2.78 | |
X73066 | NME1 | Non-metastatic cells 1, protein (NM23A) expressed in | 2.32 | 3.00 | |
AI347088 | NA | qp60d09.x1 | 2.32 | 2.21 | |
U37689 | POLR2H | Polymerase (RNA) II (DNA directed) polypeptide H | 2.32 | 2.13 | |
U86529 | GSTZ1 | Glutathione transferase zeta 1 | 2.32 | 2.28 | |
J03133 | SP1 | SP1 (SV40 promoter 1) transcription factor | 2.31 | 4.73 | |
AB007447 | FLN29 | FLN29 gene product (TNF receptor factor-like protein) | 2.30 | 2.34 | |
X74008 | PPP1CC | Protein phosphatase 1, catalytic subunit, gamma isoform | 2.30 | 2.07 | |
U56833 | VBP1 | von Hippel-Lindau binding protein 1 | 2.29 | 2.16 | |
AF020038 | IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | 2.29 | 3.40 | |
U63809 | PAWR | PRKC (protein kinase C), apoptosis, WT1, regulator | 2.29 | 2.35 | |
AL050034 | ADPRTL3 | ADP-ribosyltransferase-like 3 | 2.25 | 2.09 | |
M87339 | HUMACT1A | Human replication factor C, 37-kDa subunit | 2.25 | 2.98 | |
AA056747 | NA | zk81f02.s1 | 2.24 | 2.95 | |
U10886 | PTPRJ | Protein tyrosine phosphatase, receptor type, J | 2.23 | 2.52 | |
X84194 | ACYP1 | A-cylphosphatase 1, erythrocyte (common) type | 2.23 | 4.40 | |
AB024401 | ING1 | Inhibitor of growth family, member 1 | 2.20 | 14.85 | |
M19481 | FST | Follistatin | 2.20 | 2.54 | |
AF006084 | ARPC1B | Actin related protein 2/3 complex, subunit 1B, | 2.19 | 3.71 | |
Y00097 | ANXA6 | Annexin A6 | 2.19 | 2.00 | |
D00017 | ANXA2 | Annexin A2 | 2.18 | 2.81 | |
U50079 | HDAC1 | Histone deacetylase 1 | 2.17 | 2.62 | |
AA811338 | NA | ob81g05.sl | 2.17 | 5.19 | |
M97676 | MSX1 | msh homeo box homolog 1 | 2.16 | 3.15 | |
M63573 | PPIB | Peptidylprolyl isomerase B (cyclophilin B) | 2.16 | 2.85 | |
J00314 | OK/SW-cl.56 | beta 5-tubulin | 2.16 | 2.19 | |
U30872 | CENPF | Centromere protein F | 2.16 | 2.43 | |
AA969267 | NA | on57d12.sl | 2.13 | 2.49 | |
AF053306 | BUB1B | Budding uninhibited by benzimidazoles 1 homolog beta | 2.13 | 2.04 | |
AF042384 | BC-2 | Putative breast adenocarcinoma marker | 2.12 | 2.52 | |
U32849 | NMI | N-myc (and STAT) interactor | 2.12 | 2.90 | |
AB028975 | KIAA1052 | KIAA1052 protein | 2.12 | 2.53 | |
AJ000480 | C8FW | Phosphoprotein regulated by mitogenic pathways | 2.11 | 4.49 | |
D50692 | MYCBP | c-myc binding protein | 2.10 | 3.00 | |
M16279 | CD99 | CD99 antigen | 2.10 | 2.94 | |
X69398 | CD47 | CD47 antigen (Rh-related antigen) | 2.09 | 2.17 | |
AF054825 | VAMP5 | Vesicle-associated membrane protein 5 | 2.09 | 2.69 | |
D37984 | RECQL | RecQ protein-like (DNA helicase Q1-like) | 2.09 | 2.27 | |
U90549 | HMGN4 | High mobility group nucleosomal binding domain 4 | 2.09 | 2.16 | |
AF087036 | MSC | Musculin (activated B-cell factor-1) | 2.08 | 2.67 | |
J04058 | ETFA | Electron-transfer-flavoprotein, alpha polypeptide | 2.06 | 2.54 | |
X62534 | HMGB2 | High-mobility group box 2 | 2.04 | 2.26 | |
S57501 | NA | Protein phosphatase 1, alpha catalytic subunit | 2.04 | 2.71 | |
AJ001612 | PSPHL | Phosphoserine phosphatase-like | 2.03 | 2.89 | |
AJ245416 | LSM2 | LSM2 (Sm-like protein 2) homolog, U6 small nuclear RNA associated | 2.03 | 2.18 | |
U91932 | AP3S1 | Adaptor-related protein complex 3, sigma 1 subunit | 2.03 | 2.89 | |
U74612 | FOXM1 | Forkhead box M1 | 2.02 | 2.17 | |
L42243 | IFNAR2 | Interferon (alpha, beta, and omega) receptor 2 | 2.02 | 2.88 |
Listed genes were selected by expression rate greater than 100 and more than 2-fold expression in ATL cells more than in CD4+ and CD4+CD45RO+ T cells with significant differences (P < .01). For all genes scored, the fold change was calculated by the mean expression value of ATL cells by those of CD4+ or CD4+CD45RO+ T cells. NA indicates not applicable.
Genes were already reported as genes with high expression in HTLV-1—infected T cells.
Genes were already reported as genes with high expression in ATL cells.